Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Andrea Corona Altimmunes GLP-1 drug shows positive results for alcohol use disorder On Tuesday, Altimmune announced topline data from their Phase 2 RECLAIM trial showing that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly reduced the number of heavy drinking days compared to placebo in patients with moderate to severe alcohol use disorder
Although fibroblasts account for a small amount of the heart, they are activated when the heart is damaged to promote cardiac remodeling
Ipamorelin Research Ipamorelin was first characterized as a pentapeptide that releases growth hormone from primary rat pituitary cells with a receptor profile comparable to GHRP-6, while leaving ACTH, cortisol, prolactin, and thyroid-stimulating hormone levels largely unchanged in the models tested [1]
Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities
SPSS version 19.0 software, Origin 2018 software, and Adobe Illustrator CS6 software were used for data analysis
US$ 27.22
US$ 22.24
US$ 20.36
